Duopharma Biotech Berhad

KLSE:DPHARMA 주식 보고서

시가총액: RM 1.2b

Duopharma Biotech Berhad 배당금

배당금 기준 확인 2/6

Duopharma Biotech Berhad 수익으로 충분히 충당되는 현재 수익률 2.19% 보유한 배당금 지급 회사입니다.

주요 정보

2.2%

배당 수익률

n/a

환매 수익률

총 주주 수익률n/a
미래 배당 수익률2.4%
배당금 성장-12.0%
다음 배당금 지급일n/a
전 배당일n/a
주당 배당금RM 0.028
지급 비율54%

최근 배당금 업데이트

Duopharma Biotech Berhad (KLSE:DPHARMA) Is Due To Pay A Dividend Of MYR0.005

Aug 27
Duopharma Biotech Berhad (KLSE:DPHARMA) Is Due To Pay A Dividend Of MYR0.005

Duopharma Biotech Berhad (KLSE:DPHARMA) Is Paying Out A Dividend Of MYR0.018

Apr 04
Duopharma Biotech Berhad (KLSE:DPHARMA) Is Paying Out A Dividend Of MYR0.018

Duopharma Biotech Berhad (KLSE:DPHARMA) Has Announced A Dividend Of MYR0.005

Aug 18
Duopharma Biotech Berhad (KLSE:DPHARMA) Has Announced A Dividend Of MYR0.005

Recent updates

Duopharma Biotech Berhad (KLSE:DPHARMA) Is Due To Pay A Dividend Of MYR0.005

Aug 27
Duopharma Biotech Berhad (KLSE:DPHARMA) Is Due To Pay A Dividend Of MYR0.005

Duopharma Biotech Berhad (KLSE:DPHARMA) Is Paying Out A Dividend Of MYR0.018

Apr 04
Duopharma Biotech Berhad (KLSE:DPHARMA) Is Paying Out A Dividend Of MYR0.018

Duopharma Biotech Berhad's (KLSE:DPHARMA) Intrinsic Value Is Potentially 24% Below Its Share Price

Feb 17
Duopharma Biotech Berhad's (KLSE:DPHARMA) Intrinsic Value Is Potentially 24% Below Its Share Price

These 4 Measures Indicate That Duopharma Biotech Berhad (KLSE:DPHARMA) Is Using Debt Extensively

Oct 21
These 4 Measures Indicate That Duopharma Biotech Berhad (KLSE:DPHARMA) Is Using Debt Extensively

Duopharma Biotech Berhad (KLSE:DPHARMA) Has Announced A Dividend Of MYR0.005

Aug 18
Duopharma Biotech Berhad (KLSE:DPHARMA) Has Announced A Dividend Of MYR0.005

Calculating The Intrinsic Value Of Duopharma Biotech Berhad (KLSE:DPHARMA)

Aug 07
Calculating The Intrinsic Value Of Duopharma Biotech Berhad (KLSE:DPHARMA)

Duopharma Biotech Berhad's (KLSE:DPHARMA) Shareholders Will Receive A Smaller Dividend Than Last Year

Mar 28
Duopharma Biotech Berhad's (KLSE:DPHARMA) Shareholders Will Receive A Smaller Dividend Than Last Year

Calculating The Fair Value Of Duopharma Biotech Berhad (KLSE:DPHARMA)

Mar 27
Calculating The Fair Value Of Duopharma Biotech Berhad (KLSE:DPHARMA)

We Think That There Are Issues Underlying Duopharma Biotech Berhad's (KLSE:DPHARMA) Earnings

Nov 26
We Think That There Are Issues Underlying Duopharma Biotech Berhad's (KLSE:DPHARMA) Earnings

Need To Know: The Consensus Just Cut Its Duopharma Biotech Berhad (KLSE:DPHARMA) Estimates For 2021

Nov 25
Need To Know: The Consensus Just Cut Its Duopharma Biotech Berhad (KLSE:DPHARMA) Estimates For 2021

Duopharma Biotech Berhad's (KLSE:DPHARMA) Dividend Will Be RM0.005

Aug 20
Duopharma Biotech Berhad's (KLSE:DPHARMA) Dividend Will Be RM0.005

Here's Why Duopharma Biotech Berhad (KLSE:DPHARMA) Can Manage Its Debt Responsibly

May 22
Here's Why Duopharma Biotech Berhad (KLSE:DPHARMA) Can Manage Its Debt Responsibly

Duopharma Biotech Berhad (KLSE:DPHARMA) Investors Should Think About This Before Buying It For Its Dividend

Apr 13
Duopharma Biotech Berhad (KLSE:DPHARMA) Investors Should Think About This Before Buying It For Its Dividend

A Look At The Fair Value Of Duopharma Biotech Berhad (KLSE:DPHARMA)

Mar 14
A Look At The Fair Value Of Duopharma Biotech Berhad (KLSE:DPHARMA)

Duopharma Biotech Berhad (KLSE:DPHARMA) Seems To Use Debt Quite Sensibly

Feb 12
Duopharma Biotech Berhad (KLSE:DPHARMA) Seems To Use Debt Quite Sensibly

Do Institutions Own Duopharma Biotech Berhad (KLSE:DPHARMA) Shares?

Jan 28
Do Institutions Own Duopharma Biotech Berhad (KLSE:DPHARMA) Shares?

Is Duopharma Biotech Berhad (KLSE:DPHARMA) The Right Choice For A Smart Dividend Investor?

Jan 12
Is Duopharma Biotech Berhad (KLSE:DPHARMA) The Right Choice For A Smart Dividend Investor?

결제의 안정성과 성장

배당금 데이터 가져오기

안정적인 배당: DPHARMA 의 배당금 지급은 지난 10 년 동안 휘발성이었습니다.

배당금 증가: DPHARMA 의 배당금 지급액은 지난 10 년 동안 감소했습니다.


시장 대비 배당 수익률

Duopharma Biotech Berhad 시장 대비 배당 수익률
DPHARMA 배당 수익률은 시장과 어떻게 비교되나요?
세그먼트배당 수익률
회사 (DPHARMA)2.2%
시장 하위 25% (MY)1.9%
시장 상위 25% (MY)4.8%
업계 평균 (Pharmaceuticals)6.2%
애널리스트 예측 (DPHARMA) (최대 3년)2.4%

주목할만한 배당금: DPHARMA 의 배당금( 2.19% )은 MY 시장에서 배당금 지급자의 하위 25%( 1.94% )보다 높습니다. 1.94% ).

고배당: DPHARMA 의 배당금( 2.19% )은 MY 시장에서 배당금 지급자의 상위 25% 4.84% ).


주주에 대한 수익 배당금

수익 보장: 합리적인 지급 비율 ( 54.5% )을 통해 DPHARMA 의 배당금 지급은 수익으로 충당됩니다.


주주에 대한 현금 배당금

현금 흐름 범위: 현금 지급 비율 ( 134% )이 높기 때문에 DPHARMA 의 배당금 지급은 현금 흐름으로 잘 충당되지 않습니다.


강력한 배당금 지급 기업 알아보기